Medical Marijuana, Inc. and the fast developing cannabis industry will be represented by Dr. Stuart Titus this week at the The MoneyShow Orlando from February 8-11. The leading educational and networking event for investment professionals, the MoneyShow was created to address the myriad of concerns of modern investors in our rapidly changing economy.
At the Orlando show, Medical Marijuana, Inc. is a top sponsor, taking the title of Cannabis Thought Leader for the week of the event. As in the past, the cannabis industry will be the hot topic for this premier investing event. Dr. Titus is the CEO and President of Medical Marijuana, Inc. During the event, he will be presenting a pair of informative talks – Cannabis Investing 101 and Banking on Biotech: Cannabis Meets Medicine.
Cannabis Investing 101 will cover the basics of investing in the exciting, but volatile world of cannabis. Dr. Titus will discuss ways to ensure that you are making smart investments for the future within this new market. Banking on Biotech also discusses investing in cannabis. However, Dr. Titus’s second presentation will focus on the specific role that cannabis-based prescription medications will play in the healthcare market in coming years.
In addition to the pair of talks from Dr. Titus, The MoneyShow Orlando will also feature 200 individual investing workshops, and over 100 Wall Street experts will be on hand to share their knowledge and experience with those in attendance. Visitors will also be able to demo the newest technology and investment products on the event’s exposition floor. The MoneyShow Orlando provides attendees a one-of-a-kind education into the next wave of profitable investments, including the booming cannabis industry.
The MoneyShow Orlando will be held February 8-11 at the Omni Orlando Resort at ChampionsGate.
Don’t miss this exclusive opportunity to hear our CEO speak. You can attend The MoneyShow Orlando free by registering online.
This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.